First patient enrolled in PolyActiva’s Phase 2b clinical trial

PolyActiva has announced the first U.S. patient has been enrolled in our Phase 2b clinical trial evaluating PA5108, an investigational new chemical entity, intracameral ocular micro implant, for the reduction of intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension.